Exhibit 107
Calculation of Filing Fee Tables
Form S-4
(Form Type)
SECOND SIGHT MEDICAL PRODUCTS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
CALCULATION OF REGISTRATION FEE
Security | Security Class | Fee Calculation | Amount | Proposed | Proposed Maximum | Fee Rate | Amount of | Carry | Carry | Carry | Filing Fee Previously Paid In | |
Newly Registered Securities | ||||||||||||
Fees to Be | Equity | Common Stock, no par value | 457(f)(2) | 134,349,464 | N/A | $2,465,000 | 0.0000927 | $228.51 | ||||
Total Offering Amounts | $2,465,000 | $228.51 | ||||||||||
Total Fees Previously Paid | — | |||||||||||
Total Fee Offsets | — | |||||||||||
Net Fee Due | $228.51 |
(1) | Based on the maximum number of shares of common stock, no par value (“Merger Shares”), of the registrant, Second Sight Medical Products, Inc., a California corporation (“Second Sight”), issuable in connection with the business combination (the “Merger”) to be effectuated pursuant to an agreement and plan of merger by and among Second Sight, Nano Precision Medical, Inc., a California corporation (“NPM”), and certain other parties named therein. This number of securities to be registered is based on the securities held by NPM securityholders, which will be converted into the right to receive the pro rata portion of 134,349,464 Merger Shares, as follows: (i) the aggregate number of issued and outstanding shares of NPM common stock prior to the Merger; (ii) the aggregate number shares of NPM common stock issuable upon the exercise of all NPM stock options outstanding as of immediately prior to the Merger and exercised by NPM securityholders in accordance with their terms; and (iii) the aggregate number of shares of NPM common stock issuable upon exercise of NPM warrants outstanding as of immediately prior to the Merger and exercised by NPM securityholders in accordance with their terms. |